Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{183466,
        author = {Sruthy Sunil and Devika Dinesh and Keerthi GS Nair and Shaiju S Dharan},
        title = {Methotrexate induced Pancytopenia with Oral ulcer and skin lesion},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {3},
        pages = {1868-1870},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=183466},
        abstract = {Methotrexate (MTX) is commonly used disease modifying antirheumatic drugs (DMARD) for the treatment of Autoimmune disorders such as Rheumatoid Arthritis and Psoriasis. While generally well tolerated at low doses, MTX can rarely lead to severe adverse effects including Pancytopenia. A 52-year-old female patient was admitted with complaints of multiple boils in the kin, mouth ulcer for 1 week. She recently diagnosed with Rheumatoid arthritis and was started on NSAIDs (Polmacoxib), Methotrexate, Hydroxychloroquine and Deflazacort.},
        keywords = {Methotrexate, Pancytopenia, Oral Ulcer, Skin lesion},
        month = {August},
        }